跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
combined vaccine adjuvants
首页
药物
combined vaccine adjuvants
combined vaccine adjuvants
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
METHODS AND COMPOSITIONS FOR TREATING CANCERS
EP 3833383 A1
申请人: INST NAT SANTE RECH MED
优先权: 2018
CN
EP
US
WO
5 件公开
Reducing interference between oil-containing adjuvants and surfactant-containing antigens
US 2009220547 A1
申请人: NOVARTIS VACCINES & DIAGNOSTIC
优先权: 2005
CN
US
2 件公开
CN 101267835 A
申请人: NOVARTIS VACCINES & DIAGNOSTIC
优先权: 2005
CN
Nucleic Acid of Formula (I): GIXmGn, or (II): CIXmCn, in Particular as an Immune-Stimulating Agent/Adjuvant
US 2009324584 A1
申请人: CUREVAC GMBH
优先权: 2006
EP
US
2 件公开
Use of flagellins from the genus Marinobacter as vaccination adjuvants
US 9061002 B2
申请人: GÓMEZ CASADO EDUARDO
优先权: 2010
US
2 件公开
Construction method and application of avian influenza universal vaccine with spore probiotics as mucosal delivery vector
CN 105950646 A
申请人: UNIV SUN YAT SEN
优先权: 2016
CN
2 件公开
CpG ODN with immunoregulation function and application of CpG ODN
CN 113493790 A
申请人: NANJING HUAPU BIOTECHNOLOGY CO LTD
优先权: 2020
CN
2 件公开
Immune carrier microsphere constructed by individualized MHC-II combined polypeptide, vaccine and application of immune carrier microsphere and vaccine
CN 120661626 A
申请人: SHANGHAI MICROSPHERE BIOTECHNOLOGY CO LTD
优先权: 2025
CN
2 件公开
Combined dna/protein vaccine compositions
US 2005129712 A1
申请人: REIMANN HANSJORG
优先权: 2002
US
Vaccine delivery
US 2004258702 A1
申请人: BLONDER JOAN P
优先权: 2004
US
Malaria MSP-1 C-terminal enhanced subunit vaccine
US 2008213318 A1
申请人: HAWAII BIOTECH INC
优先权: 2006
US
第 1 / 5 页
上一页
下一页
药物
反馈